of patient respondents have received treatment
The most common anti-cancer treatments received include chemo-immunotherapy, immunotherapy alone and chemotherapy alone.
Steroids were used in 32% of respondents
of respondents received treatment close to where they live
63% of respondents reported no difficulties in obtaining treatment
However, 19% indicated that travelling to and from the cancer centre was a barrier
83% were not offered the opportunity to enrol in a clinical trial
